Evidence map›Paper›PMID 22067528›Full record

ArticleDiagnostic pathology2011

Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma.

Xing Hua, Lina Yu, Xiaoxiao Huang, Zexiao Liao, Qi Xian

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Preclinical evaluation of [EJNMMI radiopharmacy and chemistry · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Therapeutic potential of [European journal of nuclear medicine and molecular imaging · 2024
    Article
  9. Article
  10. Article
  11. Initial Results ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Xing HuaDepartment of Pathology, College of Basic Medicine, Southern Medical University, 510515 Guangzhou, China.
Lina Yu
Xiaoxiao Huang
Zexiao Liao
Qi Xian
First Affiliated Hospital of Jinan University · CNNanfang Hospital · CNRed Cross Hospital · GRSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiagnosis of ductal carcinoma in situ (DCIS) in breast cancer cases is challenging for pathologist due to a variety of in situ patterns and artefacts, which could be misinterpreted as stromal invasion. Microinvasion is detected by the presence of cytologically malignant cells outside the confines of the basement membrane and myoepithelium. When malignant cells invade the stroma, there is tissue remodeling induced by perturbed stromal-epithelial interactions. Carcinoma-associated fibroblasts (CAFs) are main cells in the microenvironment of the remodeled tumor-host interface. They are characterized by the expression of the specific fibroblast activation protein-alpha (FAP-α), and differ from that of normal fibroblasts exhibiting an immunophenotype of CD34. We hypothesized that staining for FAP-α may be helpful in determining whether DCIS has microinvasion.

methods349 excised breast specimens were immunostained for smooth muscle actin SMA, CD34, FAP-α, and Calponin. Study material was divided into 5 groups: group 1: normal mammary tissues of healthy women after plastic surgery; group 2: usual ductal hyperplasia (UDH); group 3: DCIS without microinvasion on H & E stain; group 4: DCIS with microinvasion on H & E stain (DCIS-MI), and group 5: invasive ductal carcinoma (IDC). A comparative evaluation of the four immunostains was conducted.

resultsOur results demonstrated that using FAP-α and Calponin adjunctively improved the sensitivity of pathological diagnosis of DCIS-MI by 11.29%, whereas the adjunctive use of FAP-α and Calponin improved the sensitivity of pathological diagnosis of DCIS by 13.6%.

conclusionsThis study provides the first evidence that immunostaining with FAP-α and Calponin can serve as a novel marker for pathologically diagnosing whether DCIS has microinvasion.

Indexed as

Biomarkers, TumorBreast NeoplasmsCalcium-Binding ProteinsCalponinsCarcinoma, Ductal, BreastCarcinoma in SituEndopeptidasesFemaleFibroblast Activation Protein AlphaFibroblastsGelatinasesHumansImmunohistochemistryMembrane ProteinsMicrofilament ProteinsNeoplasm InvasivenessBiomarkers, TumorCalcium-Binding ProteinsCalponinsEndopeptidasesFibroblast Activation Protein AlphaGelatinasesMembrane ProteinsMicrofilament ProteinsSerine Endopeptidases

Identifiers

PMID22067528
PMCPMC3228672
OpenAlexW2125071971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.